FDA Approved: OLUMIANT — Original Application (Eli Lilly and Company)

View source ↗

Summary

This FDA page confirms the original approval of Olumiant (baricitinib) by Eli Lilly for rheumatoid arthritis, marking the first FDA approval of the medicine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Olumiant (baricitinib)

Snippet

ORIG AP for OLUMIANT (BARICITINIB)